At BiTrial, we are proud to operate in one of the most dynamic and reliable regions for clinical development: Central and Eastern Europe (CEE).
The CEE region consistently demonstrates high performance, strong regulatory compliance, and robust patient recruitment capabilities, making it an increasingly preferred destination for global clinical trials.
What the data shows:*
1️⃣ Number of FDA Inspections by Region
The CEE region maintains a healthy mid-range inspection volume
2️⃣ Outcomes of FDA Inspections in the CEE Region- The results speak for themselves:
➡️ 60.52% – No Action Indicated (NAI)
➡️ 36.14% – Voluntary Action Indicated (VAI)
➡️ 3.34% – Official Action Indicated (OAI)
These figures reinforce what we see every day → The CEE region offers high-quality clinical operations, strong investigator engagement, and reliable regulatory standards.
As a CRO headquartered in the CEE region with over 24 years of experience, BiTrial combines regional strengths with global-quality services, delivering:
✅ High enrollment speed
✅ Strong investigator networks
✅ High-quality, audit-ready data
✅ Cost-efficient yet scientifically rigorous operations
✅ Experience across diverse therapeutic areas
Unlock the potential of the CEE region! Contact us!
*Source of statistics: fda.gov